Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528]

• R. González,
• M.A. Rodríguez-Hernández,
• M. Negrete,
• K. Ranguelova,
• A. Rossin,
• C. Choya-Foces,
• P. de la Cruz-Ojeda,
• A. Miranda-Vizuete,
• A. Martínez-Ruiz,
• S. Rius-Pérez,
• J. Sastre,
• J.A. Bárcena,
• A.-O. Hueber,
• C.A. Padilla,
• J. Muntané

Affiliations

R. González

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain; Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), Madrid, Spain

M.A. Rodríguez-Hernández

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain; Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), Madrid, Spain

M. Negrete

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain

K. Ranguelova

Bruker BioSpin Corporation, Billerica, MA, USA

A. Rossin

Université Côte D'Azur, CNRS, Inserm, iBV, Nice, France

C. Choya-Foces

Research Unit, Hospital University “Santa Cristina”, Health Research Institute “La Princesa” (IIS-IP), Madrid, Spain; Biomedical Research Network Center for Cardiovascular Diseases (CIBERCV), Madrid, Spain

P. de la Cruz-Ojeda

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain

A. Miranda-Vizuete

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain

A. Martínez-Ruiz

Research Unit, Hospital University “Santa Cristina”, Health Research Institute “La Princesa” (IIS-IP), Madrid, Spain; Biomedical Research Network Center for Cardiovascular Diseases (CIBERCV), Madrid, Spain

S. Rius-Pérez

Department of Physiology, Faculty of Pharmacy, University of Valencia. Burjassot, Valencia, Spain

J. Sastre

Department of Physiology, Faculty of Pharmacy, University of Valencia. Burjassot, Valencia, Spain

J.A. Bárcena

Department of Biochemistry and Molecular Biology, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain

A.-O. Hueber

Université Côte D'Azur, CNRS, Inserm, iBV, Nice, France

C.A. Padilla

Department of Biochemistry and Molecular Biology, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain

J. Muntané

Institute of Biomedicine of Seville (IBiS), Hospital University “Virgen Del Rocío”/CSIC/University of Seville, Seville, Spain; Department of General Surgery, Hospital University ''Virgen del Rocío''/IBiS/CSIC/University of Seville, Seville, Spain; Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), Madrid, Spain; Corresponding author. Instituto de Biomedicina de Sevilla (IBiS), Av. Manuel Siurot s/n, 41013, Sevilla, Spain.